Novena is an anesthetic and medical center group in Asia. The Singapore-based organization offers services and products for the skin and body care and well-being. Today, it consists of 100 clinics, based in Singapore, China, Hong Kong, Taiwan, Korea
Novena Global Lifecare Group based in Singapore has acquired S$55 million (US$ 40.8 million) for a 55% stake in two-day surgery in Singapore.
“We are enthusiastic about this purchase because our suite of medical and esthetic facilities complements the day surgery centers. It has been acknowledged that daycare centers are more cost-effective, helping patients in the ongoing rise of health care expenses to save time and costs, “said Terence Loh, the co-founder of Novena Global’s DORR Group.
In 2016, it opened the Aptus Surgery Center at the Paragon Medical Centre, while in 2019, the Camden Medical Centre, the Novaptus Surgery Centre. All the operating theatres, including medical, dental and eye procedures, have cableless pending systems and are fitted for a variety of operations. Patients also have endoscopic diagnostic procedures done by mouth, laparoscopy, and surgery.
20 ambulatory surgical centers in Singapore were licensed by the Ministry of Health in 2019.
Novena Global was founded in 2010 and is one of the largest and most rapidly growing integrated medical and cosmetics companies in Asia. Plans for an IPO were delayed in 2018. The year before, it reported plans to raise $150 million by an inventory on the Taiwan Stock Exchange for organic and acquisition developments in North Asia regionally.
In July 2018, it signed an MoU with Yozma BioScience Holdings in Korea to commercialize its technology and jointly invest in startups.
Last year, the Chinese Healthcare Fund was formed with the private equities companies Sinopharm Capital and Cedarlake Capital Group, amounting to 150 million US dollars.